Product: Sauerkraut Fish (Szechuan Style) and Tilapia Soup with Pickled Vegetables
Companies: Frobisher International Enterprises Ltd.
Issue: Food ? Allergen ? Milk
Category: Fish and seafood (Frozen)
What to do: If you have an allergy to milk, do not consume the recalled products
Audience: General public
Recall class: Class 1
Affected products
Brand
Product
Size
UPC
Codes
3Fish
Sauerkraut Fish (Szechuan Style)
400 g
8 74718 00529 5
All codes that do not declare milk on the label
3Fish
Tilapia Soup with Pickled Vegetables
400 g
8 74718 00534 9
All codes that do not declare milk on the label
Issue
Frobisher International Enterprises Ltd. is recalling 3Fish brand Sauerkraut Fish (Szechuan Style) and Tilapia Soup with Pickled Vegetables from the marketplace because they may contain milk which is not declared on the label.
The recalled products have been sold in British Columbia.
What you should do
Check to see if you have the recalled products in your home
If you have an allergy to milk, do not consume the recalled products as they may cause a serious or life-threatening reaction
Recalled products should be thrown out or returned to the location where they were purchased
This recall was triggered by Canadian Food Inspection Agency test results.
There have been no reported reactions associated with the consumption of these products.
What is being done
The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.
The CFIA is verifying that industry is removing the recalled products from the marketplace.
Genmab A/S and BioNTech SE today announced initial data from the Phase 2 GCT1046-04 trial (NCT05117242) evaluating acasunlimab (DuoBody-PD-L1x4-1BB), an investigational bispecific antibody also known as GEN1046/BNT311, as monotherapy and in...
First Ascent Biomedical announced findings from ongoing clinical studies conducted in partnership with Florida International University, examining the company's Functional Precision Medicine (FPM) platform in adult and pediatric patients with...
Ankyra Therapeutics, a clinical-stage oncology company developing anchored immunotherapies to improve the therapeutic window for immuno-oncology drugs, announced today that it is presenting a Trial in Progress poster for the phase 1 ANCHOR clinical...
The American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) today announced an expanded collaboration to make it simpler for patients to find authoritative cancer information online. The partnership between ASCO, the...
Beverly Hills MD®, the cutting-edge skincare line created by renowned plastic surgeons Dr. John Layke and Dr. Payman Danielpour, is celebrating its 10th anniversary. Founded in 2014 by Dr. Layke and Dr. Danielpour, who co-founded the Beverly Hills...